Evidence of Maternal–Fetal Transmission of Parachlamydia acanthamoebae by Baud, David et al.
LETTERS
Evidence of 
Maternal–Fetal 
Transmission of 
Parachlamydia 
acanthamoebae
To the Editor:  Parachlamydia 
acanthamoebae is a recently identi-
ﬁ  ed agent of pneumonia (1–3) and has 
been linked to adverse pregnancy out-
comes, including human miscarriage 
and bovine abortion (4,5). Parachla-
mydial sequences have also been de-
tected in human cervical smears (4) 
and in guinea pig inclusion conjunc-
tivitis (6). We present direct evidence 
of maternal–fetal transmission of P. 
acanthamoebae.
We tested 78 amniotic ﬂ  uid sam-
ples from patients who delivered pre-
maturely (deﬁ  ned as spontaneous de-
livery before 37 weeks of gestation) 
at the Centre Hospitalier Universitaire 
Vaudois, Lausanne, Switzerland, from 
2003 to 2006. DNA was extracted by 
using the QIAampDNA Mini kit (QIA-
GEN, Hilden, Germany) and was test-
ed by using a speciﬁ  c Parachlamydia 
real-time PCR (7). One positive sample 
(threshold cycle of 34.2) was conﬁ  rmed 
by using the 16SigF-Rp2Chlam PCR, 
which targets a large DNA segment of 
the 16S rRNA gene (8). Because these 
2 PCRs target different DNA segments, 
the positive PCR results were not due 
to PCR contamination with amplicons. 
The sequence exhibited 99.6% similar-
ity with P. acanthamoebae strain Hall’s 
coccus (1) (GenBank accession no. 
AF366365).
The sample was obtained from a 
29-year-old woman during her second 
pregnancy, at 16 weeks of gestation. 
Amniocentesis was performed because 
a ﬁ  rst-trimester test suggested a Down 
syndrome risk of 1/100. At the time of 
amniocentesis, the patient had cough 
and ﬂ  u-like symptoms of 3 weeks’ du-
ration, which resolved spontaneously 
in a few weeks. Cytogenetic analysis 
showed a normal 46XX karyotype; 
amniotic ﬂ  uid culture remained sterile. 
The pregnancy ended prematurely at 
35 weeks and 6 days with the vaginal 
delivery of a 2,060-g newborn (<5th 
percentile). The mother and child had 
an uneventful hospital course.
The role of Parachlamydia as the 
etiologic agent of premature labor and 
intrauterine growth retardation is like-
ly because 1) all vaginal, placental, 
and urinary cultures were negative; 
2) results of routine serologic tests 
were negative; and 3) only Parachla-
mydia was detected in the amniotic 
ﬂ  uid. Intrauterine infection caused by 
Parachlamydia spp. may be chronic 
and asymptomatic until adverse preg-
nancy outcomes occur (4).
The infection of this pregnant 
woman might have occurred through 
zoonotic contact through her work as a 
butcher in a rural area known for cattle 
breeding. Of interest, a recent study of 
482 healthy Swiss men found 3 who 
were seropositive for Parachlamydia 
sp., and all 3 came from the same ru-
ral area near Lausanne (within <20-
km radius) (9). Moreover, the patient 
owns 2 guinea pigs, potential vectors 
of the bacterium (6). Other modes of 
transmission are possible, e.g., con-
taminated water (free-living amebae 
may serve as hosts for Parachlamydia 
spp. and are widespread in water net-
works) and ingestion of undercooked 
meat or contaminated cow milk.
A plausible pathogenic scenario 
for this case of possible maternal–
fetal transmission of P. acanthamoe-
bae might include bacteremia in the 
context of a lung infection. This could 
have resulted in intrauterine infection 
and intrauterine growth restriction.
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Emerging 
Mycobacteria spp. 
in Cooling Towers
To the Editor: The importance of 
nontuberculous mycobacteria (NTM) 
in various clinical situations recently 
has increased. Members of the My-
cobacterium avium complex (MAC) 
cause a high percentage of infections 
in persons with acquired immunode-
ﬁ  ciency syndrome. Some species are 
considered emerging pathogens, par-
ticularly those of the M. chelonae–M. 
abscessus group. They occur not only 
in immunocompromised persons but 
also in persons without predispos-
ing conditions. Although sources of 
infection are considered to originate 
from the human environment, until 
now cooling towers were not clearly 
demonstrated to be one of these con-
tamination sources, despite being sus-
pected (1). Natural streams, ground-
water, brook waters, and swamps 
already were reported to contain dif-
ferent species of NTM. Constructed 
environments, such as hospital hot 
water systems, aerosols from showers, 
ice machines, swimming pools, dental 
unit water, endoscopes, and broncho-
scopes are other sources (2). Other 
studies have shown members of MAC 
in drinking-water distribution systems 
(3).
A 1999 study in South Africa re-
ported the presence of mycobacteria in 
cooling towers but reported no details 
about species (4). In 2003, cooling 
towers were reported to be a potential 
source of slow-growing mycobacterial 
species (1). Some mycobacterial spe-
cies recently were shown to survive 
within amebae (5). We aimed to study 
the population of ameba-associated 
mycobacterial species in 3 cooling 
towers using a co-coculture method.
These cooling towers (E, H, and 
O), located in downtown Paris, France, 
were sampled in May 2006. Water was 
taken in a sample point of the cooling 
circuit located just before the entrance 
of the tower basins. Because these 
cooling towers are regularly treated by 
oxidizing biocide BCDMH (1-bromo-
3-chloro-5, 5-dimethylhydantoin) to 
prevent development of Legionella 
spp., no Legionella spp. or Legionella-
like amebal pathogens were isolated.
Two liters of water samples were 
ﬁ  ltrated  through  0.22-μm pore-sized 
ﬁ  lters that were injected onto amebal 
microplates as previously described (6) 
and incubated at 32°C. We screened 
amebal microplates by examination un-
der inverted microscope and by Ziehl-
Nielsen, Gram, and Gimenez staining. 
Positive wells were subcultured on ax-
enic medium and incubated at 32°C for 
10 days. Acid-fast isolates were identi-
ﬁ  ed by using partial rpoB gene ampliﬁ  -
cation and sequencing with Myco-F and 
Myco-R primers (7). These primers did 
not allow ampliﬁ  cation of partial rpoB 
gene for the 6 M. phocaicum strains. 
We thus used Myco-F/Myco-Rbon 
(5′-AGCGGCTGCTGGGTGATCAT- 
3′) primer pair for M. phocaicum (8). 
We compared these sequences with 
the rpoB gene sequence of Mycobac-
teria type strains available in the Gen-
eBank database by using BLASTn on 
the NCBI website (www.ncbi.nlm.nih.
gov).
We observed bacteria growing in 
amebae. Subculture on axenic media 
led to polymicrobial cultures and al-
lowed isolation of 33 mycobacterial 
strains (Table). All these strains were 
submitted to molecular identiﬁ  cation. 
The 33 isolates corresponded to 5 
mycobacterial species: M. fortuitum, 
M. conceptionense, M. chelonae, M. 
chimaera, and M. phocaicum (Table). 
Some of these mycobacteria already 
had been shown to survive in free-
living amebae and to be implicated in 
human diseases, such as M. chelonae 
(5). The same author demonstrated 
recently that 26 environmental myco-
bacteria survived in the trophozoites 
and cysts of Acanthamoeba polypha-
ga ( 5). The recently described spe-
cies M. phocaicum was isolated only 
in samples from humans and was as-
sociated with chronic pneumonia (9). 
However, the natural source of this 
species is still unknown. M. fortuitum 
was described as an opportunistic My-
cobacterium associated with dissemi-
nated infections in a leukemia patient 
or in furunculosis after footbath in nail 
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Table. Identification of isolated nontuberculous mycobacteria according to their rpoB gene sequence similarity and GenBank 
accession numbers 
Closest officially described 
species (rpoB) Isolates (no.), N = 33 
Range in % gene similarity to type 
strain (GenBank accession no.) 
Accession numbers of
sequences of isolates 
Mycobacterium chelonae O (2), E (2)  99.7 (AY147163)  EU770577
M. conceptionense O (12)  99.2–99.9 (AY859695)  EU770583, EU770584 
M. fortuitum E (2), H (5), O (3)  99.5–99.7 (AY147165)  EU770578, EU770579, EU770580 
M. chimaera H (1)  99.7 (EF521908)  EU770576
M. phocaicum E (5), O (1)  98.3–98.6 (AY859693)  EU770581, EU770582 